Industrial Purity 6-(Trifluoromethyl)Pyridine-3-Carboxylic Acid Specs
- Strict HPLC verification ensures >98% assay for critical fluorinated intermediates.
- Comprehensive impurity profiling limits halogenated byproducts and residual solvents.
- Batch-to-batch consistency protocols support scalable custom synthesis and bulk procurement.
In the realm of advanced pharmaceutical and agrochemical manufacturing, the reliability of fluorinated building blocks is paramount. 6-(trifluoromethyl)pyridine-3-carboxylic acid (CAS: 231291-22-8) serves as a critical Fluorinated pyridine derivative used in the construction of kinase inhibitors and novel heterocyclic scaffolds. Ensuring industrial purity for this compound requires rigorous analytical verification and robust supply chain management. As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. adheres to strict quality assurance protocols to deliver material suitable for large-scale process chemistry.
This technical overview details the specification standards, analytical verification methods, and procurement guidelines necessary for sourcing high-quality intermediates. Understanding the physicochemical properties and potential impurity profiles is essential for process chemists optimizing downstream reactions.
HPLC Purity Verification Methods
Accurate determination of assay purity is the cornerstone of quality control for 6-CF3-nicotinic acid. Standard industrial protocols typically employ Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) coupled with UV detection. The trifluoromethyl group introduces specific electronic properties that influence retention times on C18 columns.
For reliable quantification, the mobile phase often consists of a buffered aqueous component mixed with an organic modifier such as acetonitrile or methanol. Detection is usually performed at 254 nm or 210 nm to capture both the aromatic ring and the carboxylic acid functionality. A robust method will demonstrate peak symmetry and resolution from known process-related impurities.
| Parameter | Specification Standard | Analytical Method |
|---|---|---|
| Assay (Purity) | ≥ 98.0% (Area Normalization) | HPLC-UV |
| Identification | Matches Reference Standard | FTIR / NMR |
| Loss on Drying | ≤ 0.5% | Karl Fischer / LOD |
| Residual Solvents | Compliant with ICH Q3C | GC-Headspace |
Validation of the analytical method ensures that the reported purity reflects the actual content of the active intermediate. Deviations in pH of the mobile phase can significantly alter the ionization state of the carboxylic acid, leading to peak broadening. Therefore, buffering agents are critical for maintaining reproducibility across different laboratory settings.
Impurity Profile Limitations
The synthesis route for fluorinated nicotinic acids often involves oxidation of methyl precursors or hydrolysis of nitrile derivatives. Each pathway introduces specific potential impurities that must be controlled to prevent interference in subsequent coupling reactions. Common impurities include positional isomers, unreacted starting materials, and over-oxidized byproducts.
Limiting halogenated impurities is particularly important when the intermediate is used in catalytic cross-coupling reactions, where trace halides can poison catalysts. Furthermore, residual heavy metals from oxidation steps must be quantified and reduced to acceptable limits. A comprehensive Certificate of Analysis (COA) should detail these specific impurity limits rather than providing a generic purity statement.
Key Impurity Controls
- Positional Isomers: Separation from 2-(trifluoromethyl) or 4-(trifluoromethyl) isomers must be confirmed via chromatographic resolution.
- Residual Halides: Chloride or bromide content should be monitored if halogenated reagents are used in the synthesis route.
- Organic Volatiles: Solvents such as DMF, DMSO, or toluene must be reduced to ppm levels suitable for pharmaceutical use.
Process chemists should review the impurity profile against their specific downstream process requirements. NINGBO INNO PHARMCHEM CO.,LTD. provides detailed impurity data upon request to facilitate risk assessment during process development.
Batch-to-Batch Consistency Protocols
Scaling from gram-scale research to kilogram-level production introduces variability risks. Maintaining batch-to-batch consistency requires standardized operating procedures (SOPs) throughout the manufacturing process. This includes controlled reaction temperatures, precise stoichiometry, and consistent work-up procedures.
For bulk procurement, buyers should request comparative COAs from multiple production lots to verify consistency. Variations in particle size or crystal form can also impact dissolution rates during reaction setup. A reliable global manufacturer will implement statistical process control to minimize these variations, ensuring that the bulk price reflects consistent quality rather than variable grades.
Procurement and Documentation Standards
Securing the necessary documentation is a critical step in the supply chain validation process. When sourcing high-purity 6-(Trifluoromethyl)nicotinic Acid, buyers should ensure that all technical dossiers are complete. This includes the COA, MSDS, and stability data.
If a Certificate of Analysis is not immediately available on the product portal, a structured request process should be followed. Buyers should contact technical support providing the specific product name, desired batch number, and company contact information. Explicitly stating the requirement for a COA ensures the regulatory team prioritizes the request. Follow-up communications should be documented to maintain a clear audit trail.
| Chemical Property | Value |
|---|---|
| CAS Number | 231291-22-8 |
| Molecular Formula | C7H4F3NO2 |
| Molecular Weight | 191.109 g/mol |
| Appearance | Off-white to Light Yellow Solid |
| Storage Conditions | Sealed, Dry, Room Temperature |
Transparency in documentation supports quality assurance initiatives and regulatory filings. Whether for custom synthesis projects or standard stock supply, access to accurate data prevents delays in production schedules. Suppliers capable of providing rapid delivery and comprehensive technical support offer significant value in high-pressure development environments.
In conclusion, the specification of 6-(trifluoromethyl)pyridine-3-carboxylic acid extends beyond simple purity percentages. It encompasses a holistic view of impurity profiles, analytical verification, and supply chain reliability. Partnering with an experienced manufacturer ensures that these technical requirements are met consistently, supporting efficient drug discovery and process scale-up.